Double-S: a Wearable Device for Erectile Dysfunction
Launched by STANFORD UNIVERSITY · Jul 6, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
The Double-S trial is studying a new wearable device designed to help men with erectile dysfunction (ED). This condition can make it difficult to achieve or maintain an erection, and it can be caused by various factors, including medical treatments for prostate cancer or emotional issues. The goal of this study is to see how well this device works for men who are experiencing moderate to severe ED.
To participate in this trial, men aged 18 and older who are struggling with erectile dysfunction can join, provided they have a female partner willing to take part as well. However, men who are not interested in trying sexual intercourse or cannot use the device for any reason will not be eligible. Participants can expect support throughout the study as they use the device, and it may provide a new option for improving their sexual health and relationships. If you think you might qualify and are interested, this trial is currently recruiting participants.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • males \>18 years old suffering from any cause moderate to severe erectile dysfunction (e.g. ED after radical prostatectomy and/or radiation therapy for prostate cancer and or other pelvic malignancies affecting the sexual potency; emotional and psychological ED; organic vascular and/or metabolic ED etc.)
- • having a female partner willing to participate in the study
- Exclusion Criteria:
- • not willing to attempt sexual vaginal intercourse with their partner
- • inability to wear/operate the external penile device for any reason
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Patients applied
Trial Officials
Michael Eisenberg, MD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials